Royal Bank of Canada raised its price target for Apogee Therapeutics on July 10, 2026, with Mizuho Securities also updating its ratings.
1 report, 1 independent
Updated Jul 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Royal Bank of Canada raised its price target for Apogee Therapeutics on July 10, 2026, with Mizuho Securities also updating its ratings.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Royal Bank of Canada
financial institution in Canada
-
Mizuho Securities
Japanese investment banking company
Nothing else this week.
Related events
- Mizuho Securities boosted its target price on Dominion Energy stock and filed with the SEC regarding stock purchases.
- Mizuho Securities, Royal Bank of Canada, and Citigroup raised their price targets and ratings for Welltower Inc. on September 5, 2026.
- Mizuho Securities lifted its price target and disclosed a transaction involving Guardant Health in an SEC filing.
- Mizuho and Royal Bank of Canada raised price targets and gave outperform ratings for GE Vernova shares.
- Analyst raised price target and gave outperform rating for Aramark on August 19, 2026.